PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER

被引：0
|
作者：
Muldong, Michelle
Lee, Sanghee
Mendoza, Theresa
Burner, Danielle
Wu, Christina
Murtadha, Jamillah
Koutouan, Evodie
Pineda, Naomi
Pineda, Gabriel
Lennon, Kathleen
Hao Pham
Willert, Karl
Cacalano, Nicholas
Jamieson, Catriona
Gaasterland, Terry
Kane, Christopher
Kulidjian, Anna
Jamieson, Christina
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD07-04
引用
收藏
页码：E99 / E99
页数：1
相关论文
共 50 条
  • [1] PRE-CLINICAL STUDIES TO ADVANCE ZILOVERTAMAB-BASED ANTI-ROR1 DUAL SPECIFICITY CAR T-CELL THERAPY FOR METASTATIC PROSTATE CANCER.
    Jamieson, Christina
    Murtadha, Jamillah
    Oh, Christopher S.
    Muldong, Michelle
    Koutouan, Evodie
    Kim, JongWook
    Etemadfard, Niloofar
    Choo, Hae Soo
    Sinha, Navyaa
    Pineda, Gabriel
    Lennon, Kathleen
    Wu, Christina N.
    Kipps, Thomas J.
    Jamieson, Catriona
    Kane, Christopher
    Mckay, Rana
    Gaasterland, Terry
    Kulidjian, Anna
    Prussak, Charles
    Cacalano, Nicholas
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [2] Pre- clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer
    Jamieson, Christina A. M.
    Murtadha, Jamillah
    Oh, Christopher S.
    Muldong, Michelle
    Koutouan, Evodie
    Kim, JOngwook
    Etemadfard, Niloofar
    Choo, Hae Soo
    Sinha, Navyaa
    Lee, Sanghee
    Wu, Christina
    Pineda, Gabriel
    Lennon, Kathleen
    Willert, Karl
    Jamieson, Catriona H.
    Gaasterland, Terry
    Mckay, Rana
    Kane, Christopher J.
    Kipps, Thomas J.
    Kulidjian, Anna A.
    Cacalano, Nicholas A.
    Prussak, Charles
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Preclinical evaluation of anti-ROR1 CAR T cells employing a ROR1 binding SCFV derived from the clinical stage mab cirmtuzumab
    Prussak, Charles E.
    Oh, Christopher
    Lujan, Juliana Velez
    Lam, Sharon
    Zhang, Jieyu
    Fernandez, Jayde
    Sinha, Navyaa
    Pham, Jessica
    Shi, Haoming
    Shin, Caitlin
    Kaufman, Gunnar F.
    Widhopf, George F., II
    Cohen, Ezra E. W.
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [4] PRE-CLINICAL EVALUATION OF THE NOVEL THERAPIES OF THE CASTRATION-RESISTANT PROSTATE CANCER
    Charbit, David
    El Sayed, Ihsan
    Masson-Lecomte, Alexandra
    Saldana, Carolina
    Salomon, Laurent
    Vacherot, Francis
    De La Taille, Alexandre
    JOURNAL OF UROLOGY, 2015, 193 (04): : E676 - E676
  • [5] Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study
    Lee, Hun Ju
    Choi, Michael Y.
    Siddiqi, Tanya
    Wierda, William G.
    Barrientos, Jacqueline C.
    Lamanna, Nicole
    Goldenberg, Alec
    Isufi, Iris
    Tuscano, Joseph
    Subbiah, Suki
    Koff, Jean L.
    Leslie, Lori A.
    Chung, Gina G.
    Weihe, Elizabeth K.
    Ianopulos, Xen
    Breitmeyer, James B.
    Hsu, Frank J.
    Wang, Michael
    Jamieson, Catriona
    Kipps, Thomas J.
    BLOOD, 2020, 136
  • [6] Clinical Activity of Cirmtuzumab, an Anti-ROR1 Antibody, in Combination With Ibrutinib: Interim Results of a Phase Ib/II Study in Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 13 - 13
  • [7] Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer
    Huffman, Kenneth
    Martinez, Elisabeth D.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [8] Clinical Activity of Cirmtuzumab, an Anti-ROR1 Antibody, in Combination With Ibrutinib: Interim Results of a Phase Ib/II Study in Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 6 - 8
  • [9] Pre-clinical assessment of EpCAM as a target for antibody based therapies of gastric cancer
    Kobold, S.
    Henkel, J.
    Steffen, J.
    Grassmann, J.
    Zimmermann, W.
    Bourquin, C.
    Endres, S.
    IMMUNOLOGY, 2012, 137 : 721 - 721
  • [10] Clinical activity of cirmtuzumab, an anti-ROR1 antibody, in combination with ibrutinib: Interim results of a phase Ib/II study in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).
    Lee, Hun Ju
    Choi, Michael Y.
    Siddiqi, Tanya
    Wierda, William G.
    Claudia Barrientos, Jacqueline
    Lamanna, Nicole
    Goldenberg, Alec
    Isufi, Iris
    Tuscano, Joseph M.
    Subbiah, Suki
    Weihe, Elizabeth Kristine
    Ianopulos, Xen
    Breitmeyer, James Bradley
    Hsu, Frank J.
    Wang, Michael
    Jamieson, Catriona Hm
    Kipps, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345